Mitsubishi UFJ Asset Management Co., Ltd. - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 455 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
Mitsubishi UFJ Asset Management Co., Ltd. ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$228,015
+8.3%
1,881
+2.3%
0.00%
Q2 2023$210,488
-39.2%
1,838
-26.8%
0.00%
-100.0%
Q1 2023$346,091
+17.2%
2,511
+6.1%
0.00%0.0%
Q4 2022$295,371
-26.5%
2,366
-34.9%
0.00%0.0%
Q3 2022$402,000
+50.0%
3,637
+1.6%
0.00%0.0%
Q2 2022$268,000
-12.7%
3,580
-9.0%
0.00%0.0%
Q1 2022$307,000
-3.2%
3,936
+12.1%
0.00%0.0%
Q4 2021$317,000
-13.9%
3,511
-11.7%
0.00%
-50.0%
Q3 2021$368,000
+22.3%
3,978
+2.6%
0.00%0.0%
Q2 2021$301,000
-78.0%
3,876
-78.9%
0.00%
-77.8%
Q1 2021$1,369,000
-50.4%
18,371
+13.5%
0.01%
-57.1%
Q4 2020$2,760,000
+32.2%
16,189
+8.9%
0.02%
+10.5%
Q3 2020$2,088,000
+1.5%
14,871
+15.9%
0.02%
-20.8%
Q2 2020$2,057,000
+76.7%
12,826
+7.8%
0.02%
+33.3%
Q1 2020$1,164,000
-34.5%
11,898
-13.2%
0.02%
-21.7%
Q4 2019$1,778,000
+93.1%
13,701
+12.0%
0.02%
+53.3%
Q3 2019$921,000
+509.9%
12,233
+1129.4%
0.02%
+400.0%
Q2 2019$151,000
-8.5%
995
-28.1%
0.00%0.0%
Q1 2019$165,000
+26.9%
1,384
+13.5%
0.00%0.0%
Q4 2018$130,000
-45.8%
1,219
-17.8%
0.00%
-40.0%
Q3 2018$240,000
-7.3%
1,483
-78.2%
0.01%
-28.6%
Q2 2013$259,0006,8000.01%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Casdin Capital, LLC 1,315,000$170,397,70013.20%
EcoR1 Capital, LLC 2,999,453$388,669,12011.83%
Evolutionary Tree Capital Management, LLC 63,756$8,261,5027.93%
Tri Locum Partners LP 119,695$15,510,0006.27%
Avoro Capital Advisors LLC 3,175,000$411,416,5006.15%
Camber Capital Management LP 1,250,000$161,9755.56%
Finepoint Capital LP 131,457$17,0345.51%
ACUTA CAPITAL PARTNERS, LLC 67,500$8,746,6505.38%
Logos Global Management LP 220,000$28,507,6003.34%
AFG FIDUCIARY SERVICES LIMITED PARTNERSHIP 33,454$3,401,6573.20%
View complete list of SAREPTA THERAPEUTICS INC shareholders